TransMedics CFO receives stock grant, 34.4K options

The option's vesting starts on September 21, 2027, and continues monthly over three years thereafter, subject to continued service.

Rhea-AI Filing Summary

TransMedics Group, Inc. Chief Financial Officer and Treasurer Fernando N. Araujo received 22,969 restricted stock units and an option covering 34,419 shares on October 28, 2026. Each RSU is a contingent right to receive one share of common stock. The option has a $66.90 per-share exercise price and expires October 28, 2036.

The option vests as to 25% of the underlying shares on September 21, 2027, with the remaining shares vesting in equal monthly installments over three years thereafter, subject to continued service.

Insider Trade Summary

Grant/Award: 57,388 shares

Grant/Award 2 txns

Insider Araujo Fernando N.

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F2	34,419	$0.00	$0.00
Grant/Award	Common Stock F1	22,969	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 34,419 contracts (Direct); Common Stock — 22,969 shares (Direct)

Footnotes (2)

1. F1. Consists of 22,969 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
2. F2. The option vests as to 25% of the shares underlying the option on September 21, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

Key Figures

Restricted stock units: 22,969 units Option shares: 34,419 shares Exercise price: $66.90 per share +3 more

6 metrics

Restricted stock units 22,969 units Granted October 28, 2026; each represents a contingent right to receive one common share

Option shares 34,419 shares Option granted October 28, 2026

Exercise price $66.90 per share Option

Initial vesting 25% of underlying shares Vests September 21, 2027, subject to continued service

Subsequent vesting period Three years Remaining shares vest in equal monthly installments thereafter, subject to continued service

Option expiration October 28, 2036 Option granted October 28, 2026

Key Terms

restricted stock units, contingent right, vests, exercise price

4 terms

restricted stock units financial

"Consists of 22,969 restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"contingent right to receive one share"

vests financial

"option vests as to 25% of the shares"

exercise price financial

"Stock Option (Right to Buy)"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did TMDX's CFO receive?

Fernando N. Araujo, TransMedics Group's Chief Financial Officer and Treasurer, received 22,969 restricted stock units and an option covering 34,419 shares on October 28, 2026. Each RSU represents a contingent right to receive one share of common stock. The option has an exercise price of $66.90 per share.

When does TMDX's CFO's option vest?

The option vests as to 25% of the underlying shares on September 21, 2027, with the remaining shares vesting in equal monthly installments over three years thereafter, subject to continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/30/2026 - 04:15 PM EDT Accepted by SEC EDGAR 10/30/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Araujo Fernando N.

(Last) (First) (Middle)

C/O TRANSMEDICS GROUP, INC.

200 MINUTEMAN ROAD

(Street)

ANDOVER MASSACHUSETTS 01810

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TransMedics Group, Inc. [ TMDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/28/2026		A		22,969(1)	A	$0	22,969	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$66.9	10/28/2026		A		34,419		(2)	10/28/2036	Common Stock	34,419	$0	34,419	D

Explanation of Responses:

1. Consists of 22,969 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

2. The option vests as to 25% of the shares underlying the option on September 21, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

Remarks:

Chief Financial Officer and Treasurer

	By: /s/ Matthew S. Forsyth, Attorney-in-Fact	10/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)